Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Mechanism Gene silencing, Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 2 | CN | 19 Dec 2016 | |
Lung Cancer | Phase 2 | CN | 18 Dec 2016 | |
Non-Small Cell Lung Cancer | Phase 1 | CN | - | |
Non-Small Cell Lung Cancer | Phase 1 | CN | - |